Which revolutionary cancer treatment launched in 2017 became the first FDA-approved gene therapy in the United States, representing a paradigm shift in personalized medicine?

In the evolving landscape of medical product launches, breakthrough therapies have transformed treatment paradigms and patient outcomes. This poll tests your knowledge about one of the most significant pharmaceutical product launches of the 2010s that revolutionized how we treat certain diseases by targeting specific genetic mutations rather than broad symptoms. Test your knowledge about this groundbreaking approach that changed medical practice!

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Kymriah (tisagenlecleucel) - the CAR-T therapy for acute lymphoblastic leukemia
Keytruda (pembrolizumab) - the checkpoint inhibitor for multiple cancer types
Spinraza (nusinersen) - the first treatment for spinal muscular atrophy
Luxturna (voretigene neparvovec) - the gene therapy for inherited retinal disease